The Brittle IV (Brtl) mouse was developed as a knock-in model for OI type IV, by introducing a Gly349Cys substitution into one Col1a1 allele, the glycine substitution again being the most common cause of dominant OI. The gene discussed is COL1A1; the disease is osteogenesis imperfecta.